Dr. Harish G. Ahuja
Claim this profileLanglade Hospital and Cancer Center
Studies Lung Cancer
Studies Breast Cancer
37 reported clinical trials
86 drugs studied
About Harish G. Ahuja
Education:
- Obtained a Medical degree (MD) from the University of Wisconsin School of Medicine and Public Health.
- Completed Residency in Radiation Oncology at the University of Wisconsin Hospital and Clinics.
- Undertook a Fellowship in Stereotactic Radiosurgery and Brachytherapy at the same institution.
Experience:
- Currently serves as a Radiation Oncologist at Aspirus Regional Cancer Center.
Area of expertise
1Lung Cancer
Stage III
Stage II
Stage IV
2Breast Cancer
HER2 positive
ER positive
ER negative
Affiliated Hospitals
Clinical Trials Harish G. Ahuja is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Nivolumab + Ipilimumab + Sargramostim
for Advanced Melanoma
This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable) and that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Colony-stimulating factors, such as sargramostim, may increase the production of white blood cells. It is not yet known whether nivolumab and ipilimumab are more effective with or without sargramostim in treating patients with melanoma.
Recruiting1 award Phase 2 & 323 criteria
More about Harish G. Ahuja
Clinical Trial Related6 years of experience running clinical trials · Led 37 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Harish G. Ahuja has experience with
- Atezolizumab
- Carboplatin
- Fluorouracil
- Paclitaxel
- Pembrolizumab
- Cisplatin
Breakdown of trials Harish G. Ahuja has run
Lung Cancer
Breast Cancer
Non-Small Cell Lung Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Harish G. Ahuja specialize in?
Harish G. Ahuja focuses on Lung Cancer and Breast Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Harish G. Ahuja currently recruiting for clinical trials?
Yes, Harish G. Ahuja is currently recruiting for 7 clinical trials in Antigo Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Harish G. Ahuja has studied deeply?
Yes, Harish G. Ahuja has studied treatments such as Atezolizumab, Carboplatin, Fluorouracil.
What is the best way to schedule an appointment with Harish G. Ahuja?
Apply for one of the trials that Harish G. Ahuja is conducting.
What is the office address of Harish G. Ahuja?
The office of Harish G. Ahuja is located at: Langlade Hospital and Cancer Center, Antigo, Wisconsin 54409 United States. This is the address for their practice at the Langlade Hospital and Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.